<b><i>ITPA</i></b> and <b><i>SLC29A1</i></b> Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease InhibitorsAndrea Lombardi, Felicia Stefania Falvella, Giuliano Rizzardini et al.|Pharmacology|2015Cited by 2
P1168 ITPA AND SLC29A1 GENOTYPING BEFORE TRIPLE THERAPY PREDICT SEVERITY OF RIBAVIRIN-INDUCED ANEMIALaura Milazzo, Felicia Stefania Falvella, M Galli et al.|Journal of Hepatology|2014Cited by 0
High Symptom Burden in Patients With Advanced Chronic or Prolonged Infectious Diseases: Not Only PainElena Angeli, Giuliano Rizzardini, Agostino Zambelli et al.|Cureus|2024Cited by 0